Clinical role and safety of tapentadol in patients with cancer: A single-center experience.

Emi Kubo,Hiroto Ishiki,Kentaro Abe,Sawako Kaku,Sayuri Yokota,Sayaka Arakawa,Daisuke Kiuchi,Koji Amano,Eriko Satomi

Journal of opioid management（2022）

引用 1|浏览0

暂无评分

摘要

Palliative care physicians prescribed TAP for patients with NP or a history of nausea. Opioid-naive patients were preferred by oncologists. TAP has good tolerability in both groups, with a low dropout rate due to AEs.

查看译文

关键词

cancer,single-center

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要